Ying Yuan - Concepedia

Author

Ying Yuan

Second Affiliated Hospital of Zhejiang University ORCID

Also Known As

Ying Yuan, Yuan, Ying, ying yuan

Publications

204

Citations

H-Index

Concepts

All Affiliations

Second Affiliated Hospital of Zhejiang University Peking University Cancer Hospital Peking University Harbin Medical University Third Affiliated Hospital of Harbin Medical University

About

Ying Yuan is an author at Second Affiliated Hospital of Zhejiang University specializing in cancer research, cancer therapeutics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	63
2	Health Sciences	2	2	22
3	Pathology	2	2	41
4	Pharmacology	2	2	22
5	Immunology	1	1	14

Ying Yuan

Publications

139

Citations

H-Index

Page 1

	Year	Citations
A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer Ying Yuan, Lizhen Zhu, Xiaofen Li, OncoTargets and Therapy	2016	34
Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis Taotao Zhou, Jijia Sun, Li-dong Tang, Frontiers in Immunology	2023	29
Nimotuzumab combined with gemcitabine versus gemcitabine in K-RAS wild-type locally advanced or metastatic pancreatic cancer: A prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial. Shukui Qin, Yuxian Bai, Zishu Wang, Journal of Clinical Oncology Pancreatic CancerGastrointestinal OncologyMedicineGemcitabine Versus GemcitabinePathology	2022	27
A phase 2 trial of sintilimab (IBI 308) in combination with CAPEOX and bevacizumab (BBCAPX) as first-line treatment in patients with RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer. Xuefeng Fang, Chenhan Zhong, Ning Zhu, Journal of Clinical Oncology Adverse EventsGastrointestinal OncologyMedicineMetronomic TherapyImmunology	2022	14
Hepatitis B Screening Compliance and Non-compliance among Chinese, Koreans, Vietnamese and Cambodians X. Grace, Yin Tan, Min Qi Wang, Clinical Medicine Gastroenterology	2010	13
Abstract CT030: Phase I study of IBI351 (GFH925) monotherapy in patients with advanced solid tumors: Updated results of the phase I study Qing Zhou, Nong Yang, Jun Zhao, Cancer Research Advanced NsclcAbstract Ct030Health SciencesMedicineMetronomic Therapy	2023	12
Phase I dose-escalation study of IBI351 (GFH925) monotherapy in patients with advanced solid tumors. Qing Zhou, Nong Yang, Jun Zhao, Journal of Clinical Oncology Advanced NsclcKras G12cMedicineMetronomic TherapyBrachytherapy	2022	10

Page 1